Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▲ PositiveRating Change9 Oct 2026

Mafatlal Industries Ltd-$

This is to share that the CARE Ratings Limited has upgraded the Ratings of the Company. A copy of the letter dated 8th October, 2026 from CARE Ratings Limited is attached herewith.

Mafatlal Industries Ltd has announced that CARE Ratings Limited has upgraded its credit ratings to CARE A- with a stable outlook for its long-term bank facilities and CARE A2+ with a stable outlook for its short-term bank facilities.

Read more →📎 1 attachment
BSECompany Update▲ PositiveOrder Win9 Oct 2026

BEML Ltd

Received an order

BEML Ltd has received an order valued at ₹ 75.58 Crores for the export and maintenance of HMV 12x12 & HMV 8x8 to Southeast Asian region.

Read more →📎 1 attachment
BSECompany Update▲ PositiveFundraise9 Oct 2026

Popees Baby Care India Ltd

Proposed to be acquired the shares of Popees Baby Care Products Limited through swap of shares under preferential Issue.

Popees Baby Care India Ltd has proposed to acquire 99.31% of the share capital of Popees Baby Care Products Limited through a share swap arrangement, and has approved the issuance of up to 2,60,44,323 equity shares and 98,53,471 convertible warrants on a preferential basis to the shareholders of Popees Baby Care Products Limited.

Read more →📎 1 attachment
BSECompany Update▲ PositiveFundraise9 Oct 2026

Popees Baby Care India Ltd

In continuation of the Board Outcome filed for Board Meeting 08th October, 2026, Please note that Our trading window continue to close from 01st October,2026 uto 48 hrs from the declaration of Quarter 2 Financial results ended on 30th September, 2026

Popees Baby Care India Ltd has announced the outcome of its board meeting held on October 8, 2026. The board approved the increase in the authorized share capital from Rs. 10,25,00,000 to Rs. 47,00,00,000. The company also approved the execution of a share subscription and share purchase agreement with Popees Baby Care Products Limited for the acquisition of 99.31% of the share capital of the target company. The board also approved the issuance of equity shares and convertible warrants to promoters and non-promoters on a preferential basis. The company has fixed October 19, 2026, as the relevant date for the preferential issue. The notice of the 1st Extraordinary General Meeting for the financial year 2026-27 has been issued, and the meeting will be held on November 18, 2026.

Read more →📎 1 attachment
BSECompany Update▲ PositiveRegulatory8 Oct 2026

Lemon Tree Hotels Ltd

Please find enclosed herewith the disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015

Lemon Tree Hotels Ltd has received an order from the Commissioner (Appeals), Central Excise & CGST, Jaipur, setting aside a demand and penalty of ₹82,554/- imposed on its subsidiary Sukhsagar Complexes Private Limited. The order was received on October 8, 2026, and has no financial impact on the company.

Read more →📎 1 attachment
BSECompany Update▲ PositiveExpansion8 Oct 2026

Jubilant Pharmova Ltd

Intimation under regulation 30

Jubilant Pharmova Ltd announces investment of CAD 94.5 million to double production capacity of its flagship product, RUBY-FILL, through its subsidiary Jubilant Draximage Inc. The Government of Canada will provide a financial support of CAD 23.8 million to this project.

Read more →📎 1 attachment
BSECompany Update▲ PositiveOrder Win8 Oct 2026

KEC International Ltd

We are pleased to enclose a copy of the press release with respect to new orders of Rs. 1,030 Crores secured by the Company. All the orders mentioned in the enclosed press release have been received in the normal course of business.

KEC International Ltd has secured new orders worth Rs. 1,030 crores across various businesses, including transmission & distribution, renewables, and cables & conductors.

Read more →📎 1 attachment
BSEBoard Meeting▲ PositiveFundraise8 Oct 2026

Novartis India Ltd

Intimation of the Outcome of the Board Meeting held today dated October 08, 2026

Novartis India Ltd, now known as Evonile Pharma Limited, has announced the outcome of its board meeting held on October 08, 2026. The board has approved the raising of funds through a rights issue, the constitution of a rights issue committee, the approval of a postal ballot notice, and the adoption and launch of the company's new corporate website.

Read more →📎 1 attachment
← PreviousPage 32 of 355Next →